PARKMAN HEALTHCARE PARTNERS LLC

other names
{{ Info.Overview }}
Revenue {{ Info.Revenue | formatUSD }}
Headquarters {{ Info.Headquarters }}
cb

Adviser Profile
As of Date 03/28/2024
Adviser Type - Large advisory firm
Number of Employees 9 12.50%
of those in investment advisory functions 5
Registration SEC, Approved, 3/15/2019
AUM* 942,517,802 59.25%
of that, discretionary 942,517,802 59.25%
Private Fund GAV* 362,298,326 38.04%
Avg Account Size 157,086,300 32.71%
SMA’s No
Private Funds 2
Contact Info (20 xxxxxxx
Websites

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

Recent News

Reported AUM

Discretionary
Non-discretionary
592M 507M 423M 338M 254M 169M 85M
2019 2020 2021 2022 2023

Private Funds



Employees

Private Funds Structure

Fund Type Count GAV
Fund TypeHedge Fund Count1 GAV$356,305,948
Fund TypePrivate Equity Fund Count1 GAV$5,992,378

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM #Funds
Adviser VALENCE8 Hedge Fund798.4m Liquidity Fund- Private Equity Fund73.7m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV872.1m AUM909.5m #Funds4
Adviser SYCALE ADVISORS Hedge Fund1.3b Liquidity Fund- Private Equity Fund42.2m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV1.3b AUM572.1m #Funds8
Adviser WHITEFORT CAPITAL MANAGEMENT, LP Hedge Fund677.6m Liquidity Fund- Private Equity Fund7.6m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV685.2m AUM685.2m #Funds2
Adviser ALLIANCE ADVISORY & SECURITIES, LLC Hedge Fund5.5m Liquidity Fund- Private Equity Fund5.6m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV11.2m AUM608.4m #Funds2
Adviser SUPERSTRING CAPITAL MANAGEMENT LP Hedge Fund258.5m Liquidity Fund- Private Equity Fund48.9m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV307.4m AUM371.1m #Funds2
Adviser FERNWOOD INVESTMENT MANAGEMENT, LLC Hedge Fund20.5m Liquidity Fund- Private Equity Fund6.0m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV26.5m AUM435.7m #Funds2
Adviser LAGO ASSET MANAGEMENT Hedge Fund229.2m Liquidity Fund- Private Equity Fund61.9m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV291.2m AUM380.6m #Funds12
Adviser FORAGER CAPITAL MANAGEMENT, LLC Hedge Fund328.2m Liquidity Fund- Private Equity Fund22.1m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV350.3m AUM350.3m #Funds2
Adviser X-SQUARE CAPITAL Hedge Fund57.2m Liquidity Fund- Private Equity Fund106.4m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV163.6m AUM423.6m #Funds2
Adviser SEGRA CAPITAL MANAGEMENT, LLC Hedge Fund427.0m Liquidity Fund- Private Equity Fund23.0m Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV449.9m AUM449.9m #Funds2

Top Holdings

Stock Ticker Stock Name $ Position % Position $ Change # Change
Stck Ticker101137107 Stock NameBOSTON SCIENTIFIC CORP $ Position$42,478,100 % Position6.00% $ Change46.00% # Change30.00%
Stck Ticker45784P101 Stock NameINSULET CORP $ Position$36,183,749 % Position5.00% $ Change132.00% # Change97.00%
Stck Ticker91307C102 Stock NameUNITED THERAPEUTICS CORP DEL $ Position$35,480,418 % Position5.00% $ Change20.00% # Change-13.00%
Stck Ticker216648501 Stock NameCOOPER COS INC $ Position$26,923,145 % Position4.00% $ Change-7.00% # Change8.00%
Stck Ticker532457108 Stock NameELI LILLY & CO $ Position$28,658,899 % Position4.00% $ Change15.00% # Change-1.00%
Stck Ticker54300N103 Stock NameLONGBOARD PHARMACEUTICALS IN $ Position$18,763,631 % Position3.00% $ Change25.00% # Change0.00%
Stck Ticker00847X104 Stock NameAGIOS PHARMACEUTICALS INC $ Position$19,249,458 % Position3.00% $ Change # Change
Stck Ticker88033G407 Stock NameTENET HEALTHCARE CORP $ Position$19,811,759 % Position3.00% $ Change-34.00% # Change-48.00%
Stck Ticker87164F105 Stock NameSYNDAX PHARMACEUTICALS INC $ Position$12,332,330 % Position2.00% $ Change-34.00% # Change-23.00%
Stck Ticker78349D107 Stock NameRXSIGHT INC $ Position$17,854,786 % Position2.00% $ Change-16.00% # Change-28.00%

Brochure Summary

Overview

A. Parkman Healthcare Partners LLC (the “Adviser” or “Parkman”) was formed in November 2018 as a Delaware limited liability company and has its principal place of business in Stamford, Connecticut. The principal owner of Parkman is Greg Martinez (the “Principal”), who has the overall responsibility for the day-to-day supervision and management of Parkman’s business. Parkman acts as the investment manager for: (i) a sponsored master-feeder structure (the “Fund”), a sponsored special purpose vehicle (the “SPV”); and (iii) sub-advised accounts (each a “Managed Account”, which, collectively with the Fund and SPV, are referred to as the “Clients”)).1 The Fund and SPV are for sophisticated, qualified investors (“Investors”). B. Parkman pursues its investment strategy through managing its Clients. Parkman has discretion with respect to investment decisions made for the Clients. The Adviser provides its services to the Clients as described in the Client’s confidential offering memorandum and governing documents or applicable investment management agreement. Parkman’s investment strategy aims to protect and grow capital by taking long and short positions in a portfolio that consists primarily of a broad range of global equities, focusing on the healthcare sector. Parkman uses a fundamental bottom-up analysis to identify what it considers to be undervalued investments and to capture fundamental valuation
disparities. C. While each of its Clients follow the general strategy mentioned above, the Adviser may tailor the specific advisory services with respect to the individual needs of such Clients pursuant to the agreed upon terms described in the applicable governing documents, including but not limited to an investment management agreement (referred to collectively as “Offering Documents”). Each advisory agreement was separately negotiated and designed to suit the needs of the respective Client and its respective investment guidelines. Such advisory agreements may impose restrictions on Parkman’s ability to invest in certain securities or types of securities. Additional portfolio restrictions may also include exposure limits, concentration limits, industry and sector limits, geographical limits and liquidity limits. D. The Adviser will not participate in wrap fee programs. E. As of December 31, 2023, the Adviser managed $942,517,802 in regulatory assets under management on a discretionary basis. Parkman does not manage any advisory client assets on a non-discretionary basis. 1 As a registered investment adviser, the Adviser owes a fiduciary duty to all of its clients. In 2006, the decision by the Court of Appeals for the D.C. Circuit in Goldstein v. SEC, 451 F.3d 873 (D.C. Cir. June 23, 2006), with respect to private funds, clarified that the “client” of an investment adviser to a private fund is the fund itself and not an investor in the fund.